Kentaro Ikeya

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama et al. · Gastroenterology · 2017 · 196 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score

Kentaro Ikeya, Hiroyuki Hanai, Ken Sugimoto et al. · Journal of Crohn s and Colitis · 2015 · 173 citations · Full text

Medicine, Clinical Sciences, Diagnostic Assessment +15

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study

Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto et al. · Journal of Gastroenterology · 2018 · 124 citations · Full text

Life Sciences, Genetics, Pharmacology +17

Highly Bioavailable Curcumin Derivative Ameliorates Crohn’s Disease Symptoms: A Randomized, Double-Blind, Multicenter Study

Ken Sugimoto, Kentaro Ikeya, Shigeki Bamba et al. · Journal of Crohn s and Colitis · 2020 · 67 citations · Full text

Pharmacy, Pharmacotherapy, Bioavailability +16

Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study

Hiroyuki Hanai, Takayuki Iida, Ken Takeuchi et al. · Digestive and Liver Disease · 2008 · 46 citations

Medicine, Immunology, Gastroenterology +14